The drug was one of the company’s few original experimental drugs close to reaching the market
The drug was one of the company’s few original experimental drugs close to reaching the market
The new PharmaTimes Medical and Scientific Excellence Awards, designed to recognise the outstanding achievements of medical and scientific professionals will close for entry on the 31st October.
Company announces revised agreement with Galapagos
Ruling secure Biogen’s Tecfidera exclusiity until 2028.
Drug significantly extended metastasis-free survival compared to placebo
CRO hopes partnership will accelerate drugs’ time to market
Company says drug could ‘play an important role in delaying the progression of smoldering myeloma into active myeloma’
Roche Diagnostics tests among seven selected for new scheme
Includes data for head and neck cancer, biliary tract cancer and esophageal cancers
MSD’s immunotherapy improved overall survival by up to 39%
Drug improved progression-free survival by 70%
Positive results in lung and breast cancer, but Roche is still playing catch-up to rival drugs
AMI-MS delivers a twenty-fold improvement in throughput compared to traditional mass spectrometry by using sound energy
Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside Communications Team of the Year and the all-new Sales Awards.
International Clinical Researcher of the Year is celebrating its 20th anniversary in 2019. If ever there was a time to stand out against the competition and be remembered, it’s now!